MoCRA Check-In: FDA Guidance Urgently Needed As Year-End Compliance Deadlines Loom
John Bailey, independent advisor for colors and cosmetics at EAS Consulting Group, is checking in with HBW Insight periodically in 2023 to offer his views on developments under the US Modernization of Cosmetic Regulations Act of 2022. Here he discusses the urgent need for FDA guidance as deadlines creep closer for registration, product listing, safety substantiation, and adverse event reporting.
You may also be interested in...
FDA announces plans to make submission portal available in October for meeting registration deadlines for facilities and product listings under Modernization of Cosmetics Regulation Act. Guidance also provides more specifics on data that should be submitted to agency.
EAS Consulting Group’s John Bailey is checking in with HBW Insight periodically in 2023 to offer his views on developments under the US Modernization of Cosmetic Regulations Act of 2022. Here he provides his experience with, and takeaways from, the US FDA’s 1 June virtual “listening session” on good manufacturing practices for cosmetic products.
The US Food and Drug Administration will have new cosmetics requirements to enforce under the Modernization of Cosmetic Regulations Act, as well as new funds and pressure “to make a show of this,” Locke Lord attorneys said in the law firm’s 31 May “MoCRA and You” webinar.